| Phase 1 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07122401 | Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism | Secondary Hyperparathyroidism, Chronic Kidney Disease | Recruiting | 2025-10-01 |
| Phase 2 | ||||
| NCT07205328 | A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke | Acute Ischemic Stroke | Recruiting | 2025-10-03 |
| NCT06976177 | Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT)… | Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Recruiting | 2025-05-16 |
| Phase 1 | ||||
| NCT07024160 | Phase I Study of MT1011 Injection in Healthy Subjects | Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation | Recruiting | 2025-07-03 |
Chronic Kidney Disease (2) · Stroke (1)